Physician profile
Richard Clement
NPI 1144321696
$1,019.10
in general payments reported to CMS, 2019-2025
17 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $149 · 2021: $206 · 2022: $186 · 2023: $130 · 2024: $57.66 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $299.30 | 2019-2023 | Liletta |
| Organon LLC | $117.25 | 2022-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $106.85 | 2019-2022 | |
| Hologic Sales and Service, LLC | $97.10 | 2020-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Astellas Pharma US INC | $84.90 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $69.56 | 2020-2021 | |
| Pfizer INC. | $51.50 | 2019-2024 | |
| Lupin INC. | $50.19 | 2019-2020 | |
| Avion Pharmaceuticals | $27.12 | 2021 | |
| Mayne Pharma Commercial LLC | $17.38 | 2024 | |
| Coloplast Corp | $16.97 | 2019 | |
| Amgen INC. | $16.32 | 2019 | |
| Myovant Sciences INC. | $15.94 | 2022 | |
| Evofem Biosciences, INC. | $13.14 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.98 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $11.70 | 2019 | |
| Mallinckrodt Enterprises LLC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Clement listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.